If you purchase medical devices or consumables for a clinic, pharmacy, or healthcare setting, you will have come across the CE mark. Since Brexit, a second mark has entered the picture too: the UKCA. For anyone involved in procuring or managing medical supplies in the UK, understanding what these marks mean, why they matter, and what the current regulatory picture looks like is genuinely useful, both for compliance and for making confident decisions about who you source supplies from.
This article covers what the CE and UKCA marks mean, how the post-Brexit transition is playing out, and what it means in practice when buying medical consumables.
What the CE Marking Means
The CE marking stands for Conformité Européenne, French for European Conformity. It is a regulatory mark indicating that a product meets the safety, health, and performance standards required by relevant EU directives and regulations. For medical devices, the applicable framework is the EU Medical Devices Regulation (EU MDR 2017/745), which came into force in May 2021 and replaced the previous Medical Device Directives (MDD).
When a medical device carries a CE mark, it means the manufacturer has completed the required conformity assessment, which varies depending on the risk classification of the device, maintained technical documentation demonstrating compliance, and issued a Declaration of Conformity confirming the product meets all applicable requirements. For higher-risk devices, this process must be independently verified by a recognised EU Notified Body before the mark can be applied.
CE marking has been the recognised standard for medical devices across both the EU and the UK for decades. It signals that a product has gone through a structured, regulated process and provides assurance to buyers, clinicians, patients, and regulators that the device meets defined standards of safety and performance.
What the UKCA Marking Means
UKCA stands for UK Conformity Assessed. It is the UK’s own product marking, introduced following Brexit to replace the CE mark for products placed on the market in Great Britain, covering England, Wales, and Scotland. Northern Ireland is a separate case and continues to follow EU rules under the Northern Ireland Protocol, meaning CE marking remains required there.
In terms of what it actually signifies, UKCA marking works along similar principles to CE marking. Manufacturers must carry out a conformity assessment against UK regulatory requirements, maintain technical documentation, and issue a UK Declaration of Conformity. For certain device classes, assessment must be carried out by a UK Approved Body, the UK equivalent of an EU Notified Body.
The underlying technical standards and safety requirements for UKCA are largely derived from the same EU framework that underpins CE marking, meaning the practical bar for compliance is broadly comparable. The key difference is jurisdictional: CE marking gives access to the EU market, UKCA gives access to the GB market, and the two marks are not interchangeable.
The CE to UKCA Transition: Where Things Stand Right Now
The post-Brexit transition from CE to UKCA has been anything but straightforward. When the UKCA mark was introduced in January 2021, the original plan was for it to become mandatory on the GB market from July 2023, after which CE marked devices would no longer be accepted. That deadline has since been extended several times, reflecting the practical complexity of transitioning a heavily regulated industry.
At the time of writing, CE marked medical devices are still accepted in Great Britain under transitional arrangements. The current deadlines extend to June 2028 for most devices, and June 2030 for certain device classes under the EU MDR. These transitional arrangements require that the device remains unchanged and that its CE certification from an EU Notified Body remains valid.
Looking further ahead, the picture has shifted further still. The MHRA, which is the UK’s medicines and healthcare products regulator, has proposed consulting on the indefinite recognition of CE marked devices in Great Britain, a move widely seen as a signal that the hard transition to UKCA-only may never fully materialise in the form originally planned. The MHRA has also indicated it may explore reliance on approvals from trusted international regulators, including the FDA and others, as an alternative route to market.
In short, CE marking remains valid and widely accepted in the UK for the foreseeable future. The UKCA mark is a live and active route to market for manufacturers, and dual marking is possible, but for clinics and healthcare buyers, the practical implication is straightforward: products carrying a current CE mark from a reputable manufacturer remain fully compliant for use in Great Britain.
Why It Matters When Buying Medical Supplies
For clinic owners, practice managers, and pharmacy buyers, the relevance of these marks is primarily about confidence and compliance. Medical devices and consumables used in clinical settings are regulated products. Purchasing items that lack the appropriate marking or sourcing from suppliers who cannot demonstrate that the products they supply are properly certified carries real risk, both from a patient safety perspective and a regulatory one.
In practice, this means it is worth checking that any supplier you work with sources products that carry a CE or UKCA mark, can provide documentation if required, and understands the regulatory framework around the products they are selling. This is particularly relevant for consumables that might seem straightforward, such as needles, syringes, gloves, wipes, and swabs to name a few examples, but are classified as medical devices and subject to the same marking requirements and regulations as more complex equipment.
A supplier with a clinical or regulatory background is naturally better placed to navigate this. Understanding what a CE mark represents, which device classes apply to which products, and how the transition affects the supply chain is not something every distributor will have thought carefully about. It is something that a pharmacist-led business, with a working knowledge of healthcare regulation and the products being sold, is in a stronger position to apply consistently.
Our Commitment to Compliant Products
At Medix Group, we only source and supply medical devices and consumables that carry CE and/or UKCA marking, and work with reputable manufacturers and brands to ensure products we supply meet regulatory requirements and ensure safety for your clinicians and patients.
As a pharmacist-led distributor, understanding the regulatory landscape our customers operate in is something we take seriously, and it shapes how we source and select the products we carry. Whether you are restocking a phlebotomy or aesthetics clinic, a private GP practice, hospital, or a pharmacy offering health screening, you can be confident that what you order from us meets the required standards.
If you have questions about any of our products or want to discuss your clinic’s supply needs, get in touch with our team.
